文献速递眼底病与葡萄膜炎

抗VEGF治疗新生血管性年龄相关性黄斑变性的解剖与临床结局关联

ASSOCIATION BETWEEN ANATOMICAL AND CLINICAL OUTCOMES OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR.
PubMed 文献 · Retina · 2021-01-01

仅视网膜下液眼与大部分 inactive 眼12个月视力获益相似,而视网膜内液与更差视力结局相关。

要点

  • 仅视网膜下液眼12个月视力获益与大部分inactive眼相似。
  • 视网膜内液为主眼视力获益低于仅视网膜下液眼和inactive眼。
  • 初始仅视网膜内液眼最终视力比初始仅视网膜下液眼更差。

核心结论

  • 仅视网膜下液眼1年结局与大部分inactive眼相似。
  • 视网膜内液与更差视觉结局相关。
  • 管理新生血管性年龄相关性黄斑变性时需区分视网膜内液与视网膜下液。

研究设计与样本

  • 基于Fight Retinal Blindness!注册研究的观察性分析。
  • 每次随访将病灶活动度分为inactive、active not SRFL only(A-NSRFL only)或active SRFL only(A-SRFL only)。

主要发现

  • 初始A-NSRFL only眼与初始A-SRFL only眼12个月调整平均视力变化相似(5.7 vs. 6.9 letters;P = 0.165)。
  • 初始A-NSRFL only眼12个月最终视力更差(62.5 vs. 67.5 letters;P = 0.003)。
  • 主要活动状态组间12个月调整平均视力变化显著不同(P = 0.005)。
  • mostly inactive眼(7.6 letters)和mostly A-SRFL only眼(7.5 letters)视力获益高于mostly A-NSRFL only眼(3.6 letters)。

临床怎么用

  • 临床管理新生血管性年龄相关性黄斑变性时应区分视网膜内液与视网膜下液。
  • 视网膜内液为主的活动状态与更差视力结局相关,需关注此类患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Assess the relationship between subretinal fluid (SRFL), intraretinal fluid, and visual outcomes of neovascular age-related degeneration in routine clinical practice. METHODS: Treatment-naive eyes enrolled in the Fight Retinal Blindness! registry after January 2017 were identified. Lesion activity was graded at each visit as inactive, active not SRFL only (A-NSRFL only), or active SRFL only (A-SRFL only). Eyes were grouped based on initial activity as follows: 1) initially A-NSRFL only or 2) initially A-SRFL only, and their predominant activity status over 12 months was as follows: 1) mostly inactive, 2) mostly A-NSRFL only, or 3) mostly A-SRFL only. RESULTS: Seven hundred and three eyes were eligible for analysis. Initially A-NSRFL only had a similar adjusted mean 12-month visual acuity change to initially A-SRFL eyes (5.7 vs. 6.9 letters; P = 0.165), but their final visual acuity was worse (62.5 vs. 67.5 letters at 12 months; P = 0.003). The adjusted mean 12-month visual acuity change between the predominant activity groups was significantly different (P = 0.005), with mostly inactive (7.6 letters) and mostly A-SRFL only (7.5 letters) eyes gaining more than mostly A-NSRFL only eyes (3.6 letters). CONCLUSION: Eyes with SRFL only had similar outcomes at 1 year to eyes that were mostly inactive. Intraretinal fluid was associated with worse visual outcomes, highlighting the importance of distinguishing between intraretinal fluid and SRFL when managing neovascular age-related degeneration.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Nguyen V, Puzo M, Sanchez-Monroy J, et al. ASSOCIATION BETWEEN ANATOMICAL AND CLINICAL OUTCOMES OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR. Retina. 2021. PMID: 33332811. doi:10.1097/IAE.0000000000003061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。